Phase III Clinical Trials Comparing the Immunogenicity and Safety of the Vero Cell-Derived Japanese Encephalitis Vaccine Encevac with Those of Mouse Brain-Derived Vaccine by Using the Beijing-1 Strain

• Published in: Clinical and Vaccine Immunology Vol. 21; no. 2; pp. 188 - 195
• Main Authors: Miyazaki, Chiaki, Okada, Kenji, Ozaki, Takao, Hirose, Mizuo, Iribe, Kaneshige, Yokote, Hiroyuki, Ishikawa, Yuji, Togashi, Takehiro, Ueda, Kohji
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 01.02.2014
• Subjects: Animals; Child; Child, Preschool; Encephalitis, Japanese - prevention & control; Humans; Infant; Japanese Encephalitis Vaccines - administration & dosage; Japanese Encephalitis Vaccines - adverse effects; Japanese Encephalitis Vaccines - immunology; Japanese Encephalitis Vaccines - isolation & purification; Mice; Vaccines; Vaccines, Inactivated - administration & dosage; Vaccines, Inactivated - adverse effects; Vaccines, Inactivated - immunology; Vaccines, Inactivated - isolation & purification; Vero Cells
• ISSN: 1556-6811; 1556-679X
• DOI: 10.1128/CVI.00377-13

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI